Research map: PreclinicalEvaluation of [68Ga]Ga-CS03as a Novel GPC3-Targeted Probe for Imaging GPC3 in HepatocellularCarcinoma Models

Back to the article

Papers in this map

  1. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma · Andrew Xiuxuan Zhu · 2022 · 666 citations · Cited by this paper
  2. A CosmeticProduct Containing PEG Derivatives InducesAnti-PEG IgM Mainly through Stimulation of the Spleen Cells in Mice · 2026 · Related
  3. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers · Yu Wang · 2023 · 414 citations · Cited by this paper
  4. [68Ga]Ga-DOTA-DP-UBI 29-41: A Novel 68Ga-LabeledUbiquicidin 29-41 Derivative Containing d -Prolinefor Bacterial Infection PET Imaging · 2026 · Related
  5. Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment · Fubo Zhou · 2017 · 407 citations · Cited by this paper
  6. PreclinicalEvaluation of 177Lu-LabeledAnti-CLDN18.2 VHH-Fc for Radioimmunotherapy in Gastric Cancer · 2026 · Related
  7. Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials · Donghua Shi · 2020 · 386 citations · Cited by this paper
  8. Development of [111In]In-CHX-A″-DTPA-αCD68for ImmunoSPECT to Image Murine Macrophages · 2026 · Related
  9. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers · David Steffin · 2024 · 256 citations · Cited by this paper
  10. Design, Synthesis, and Preclinical Evaluation of Novel Dimeric RM2-Based Radioligands for GRPR-Targeted Breast Cancer Imaging · 2026 · Related
  11. An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors · Takahiro Ishiguro · 2017 · 213 citations · Cited by this paper
  12. IntegratingTumor Targeting and Half-Life Extensioninto a Dual-Surfaced Single-Domain ADAPT Protein · 2026 · Related
  13. Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma · Xiuqi Wu · 2019 · 160 citations · Cited by this paper
  14. Tuningthe Structural Properties of a Single-DomainAntibody Scaffold for Improved Fibroblast Activation Protein Targeting · 2026 · Related
  15. Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma · Xiufeng Zheng · 2022 · 155 citations · Cited by this paper
  16. AutomatedRadiosynthesis of High-Molar-Activity 4-Borono-2-[18F]Fluorophenylalanine: Validation in Rodent Tumor Modelsand Nonhuman Primates · 2026 · Related
  17. Glypican‐3‐Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma · Ying Fu · 2018 · 134 citations · Cited by this paper
  18. Evaluationof 161Tb-Labeled DOTA-Ibandronatefor Targeted Radionuclide Therapy in Bone Metastases · 2026 · Related
  19. Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024 · Abraham Koshy · 2024 · 122 citations · Cited by this paper
  20. Predicting pHmax and Salt DisproportionationRisk for Basic Drugs · 2026 · Related
  21. GPC3-targeted immunoPET imaging of hepatocellular carcinomas · Shuxian An · 2022 · 88 citations · Cited by this paper
  22. Glypican-3–Targeted 89 Zr PET Imaging of Hepatocellular Carcinoma · Jonathan G. Sham · 2014 · 84 citations · Cited by this paper
  23. Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners · Tetsuhiro Chiba · 2014 · 81 citations · Cited by this paper
  24. Glypican-3–Targeting F(ab′)2 for 89 Zr PET of Hepatocellular Carcinoma · Jonathan G. Sham · 2014 · 74 citations · Cited by this paper
  25. Imaging of hepatocellular carcinoma patient-derived xenografts using 89Zr-labeled anti-glypican-3 monoclonal antibody · Xiaoyang Yang · 2014 · 64 citations · Cited by this paper
  26. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET · Stanley Fayn · 2023 · 63 citations · Cited by this paper
  27. Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma · Fanching Lin · 2024 · 55 citations · Cited by this paper
  28. [ 68 Ga]Ga-RAYZ-8009: A Glypican-3–Targeted Diagnostic Radiopharmaceutical for Hepatocellular Carcinoma Molecular Imaging—A First-in-Human Case Series · Alex J. Poot · 2024 · 47 citations · Cited by this paper
  29. An innovative peptide with high affinity to GPC3 for hepatocellular carcinoma diagnosis · Qi Zhang · 2018 · 40 citations · Cited by this paper
  30. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET · Zhen Wang · 2017 · 38 citations · Cited by this paper
  31. The development of a Glypican-3-specific binding peptide using in vivo and in vitro two-step phage display screening for the PET imaging of hepatocellular carcinoma · Yushuang Qin · 2020 · 33 citations · Cited by this paper
  32. Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy · Arnaud Couzinet · 2024 · 24 citations · Cited by this paper
  33. 10P3Me: A GPC3-Targeted Peptide PET Probe for Subcutaneous and Orthotopic HCC Imaging · Chen Gong · 2025 · 9 citations · Cited by this paper

Source: OpenAlex (CC0)